Patenting Nature: What Ruling in Myriad Case Means for Biotechnology and DNA Diagnostics
Repository Usage Stats
DescriptionEditorial in 'The Cancer Letter', written by Professor Robert Cook-Deegan. This article was included in background materials provided at the September, 2011 Congressional briefing.
SubjectGenetics, Myriad Genetics, ACLU, BRCA, Breast Cancer, Amicus Brief, Gene Patents, Law, Health Policy, Medicine, Women’s Health
CitationCook-Deegan, Robert Mullan (2011). Patenting Nature: What Ruling in Myriad Case Means for Biotechnology and DNA Diagnostics. Retrieved from http://hdl.handle.net/10161/7683.
More InfoShow full item record
Research Professor in the Sanford School of Public Policy
Robert Cook-Deegan is a research professor in the Sanford School of Public Policy, with secondary appointments in Internal Medicine (School of Medicine), and Biology (Trinity College of Arts & Sciences). He was the founding director for Genome Ethics, Law & Policy in Duke’s Institute for Genome Sciences & Policy from July 2002 through December 2012. He is the author of The Gene Wars: Science, Politics, and the Human Genome and an author on over 250 art
This author no longer has a Scholars@Duke profile, so the information shown here reflects their Duke status at the time this item was deposited.